Figure 1
The distribution of patients according to HbA1c levels at the baseline and at the end of the study. V1 – visit 1 (baseline), V2 – visit 2 (the end of the study).
Figure 2
The distribution of patients according to the cardiovascular risk in men and women. V1 – visit 1 (baseline), V2 – visit 2 (the end of the study), CHD – coronary heart disease.
Figure 3
The cardiovascular risk according UKPDS risk engine in men and women. Values represents mean ± standard error of the mean. **p<0.01, ***p<0.001 vs. women, CHD – coronary heart disease.
Table 1
The cardiovascular risk according to UKPDS risk engine in men and women.
| CVD risk | Women mean (%) ± SEM (min.–max. %) | Men mean (%) ± SEM (min.–max. %) | M vs. W p < |
|---|---|---|---|
| V1 CHD | 16.58 ± 0.89 (3.10–54.90) | 30.61 ± 1.87 (4.10–75.80) | 0.001 |
| V2 CHD | 17.17 ± 1.03 (1.40–63.60) | 30.94 ± 1.75 (5.00–70.90) | 0.001 |
| V1 fatal CHD | 12.49 ± 0.84 (1.50–49.30) | 23.33 ± 1.76 (1.10–66.50) | 0.001 |
| V2 fatal CHD | 13.38 ± 0.98 (0.50–60.50) | 24.05 ± 1.70 (1.50–65.70) | 0.001 |
| V1 stroke | 9.76 ± 0.88 (1.00–55.80) | 15.99 ± 1.94 (0.90–89.20) | 0.01 |
| V2 stroke | 11.91 ± 1.00 (1.10–58.60) | 19.23 ± 2.07 (0.80–92.90) | 0.01 |
| V1 fatal stroke | 1.71 ± 0.17 (0.20–10.30) | 2.98 ± 0.41 (0.10–21.40) | 0.01 |
| V2 fatal stroke | 2.00 ± 0.19 (0.10–11.30) | 3.44 ± 0.38 (0.10–16.80) | 0.01 |
[i] V1 – beginning of the study, V2 – the end of the study, CHD – coronary heart disease, CVD – cardiovascular disease, SEM – standard error of mean